Nanoformulation Nasal Spray
Alzheimer's / Parkinson's (Symptom Management)
Pre-commercialActive
Key Facts
Indication
Alzheimer's / Parkinson's (Symptom Management)
Phase
Pre-commercial
Status
Active
Company
About MegaNano BioTech
MegaNano BioTech is a private, preclinical-stage biotech developing a versatile dendritic cell vaccine platform and related therapeutic products. The company's lead programs target Alzheimer's and Parkinson's diseases, with exploratory work in lung cancer and malaria. It is currently seeking $5-10 million in investment to advance its second Alzheimer's vaccine candidate through IND-enabling studies and Phase I clinical trials, while also preparing to commercialize a nutraceutical nasal spray.
View full company profile